Shanghai Fosun Pharmaceutical (Group) Co., Ltd.

Overview

• HeadquartersF4¹

See how the biggest companies compare on our leaderboards

Corporate structure

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. sits at the top of its group. 2 entities, 2 countries on record. Switch between the flow chart and the network, and select any entity to see its details.

Built from major holders from Schedules 13D and 13G; stakes of 5% or more it reported on Schedules 13D and 13G (1 companies). Each entity in the chart links to its source.

Filings

11 filings to the SEC since October 2021: 11 other. The latest 11:

1. Aug 30, 2024N-PX EDGAR
2. Aug 29, 2024N-PX EDGAR
3. Nov 8, 202313F-NT EDGAR
4. Aug 14, 202313F-NT EDGAR
5. Apr 28, 202313F-NT EDGAR
6. Feb 10, 202313F-NT EDGAR
7. Nov 14, 202213F-NT EDGAR
8. Aug 10, 202213F-NT EDGAR
9. May 11, 202213F-NT EDGAR
10. Feb 10, 202213F-NT EDGAR
11. Nov 12, 202113F-NT EDGAR

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Stakes it holds

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. has told the SEC it owns more than 5% of 1 company, latest first (Schedules 13D and 13G).

• Nature's Sunshine ProductsSCHEDULE 13D/A Jun 9, 2025 to Jun 27, 2025²